News

The FAMS Organising Committee is thrilled to announce planning has commenced for the 6th Food Allergen Management Symposium (FAMS), scheduled to take place from May 20th to 22nd, 2025, in Sydney. We’re reaching out early to assist with your 2025…

A report on food allergens has just been released by High-Speed Training, a private UK company. It presents data from an online YouGov survey conducted with 2,134 UK participants in January 2024. The report aims to highlight the level of…

ARS Pharmaceuticals, Inc. is a U.S. biopharmaceutical company working to develop an epinephrine (adrenaline) nasal spray called neffy® for the treatment of severe allergic reactions. The company recently held an investor day to showcase the potential benefits of the new…

The rules in Australia and New Zealand for declaring allergens in food changed in February 2024. To support food businesses in managing the requirements, the New Zealand Ministry of Primary Industry (MPI) has released a guidance document. The new ‘Plain…

A recent study has found that omalizumab, a medication commonly used to treat asthma, may also be beneficial for people with multiple food allergies. The study involved 118 participants who received omalizumab injections every two to four weeks for four…

We are thrilled to announce that Professor Dianne Campbell, an esteemed academic Paediatric Immunologist, will be joining the VITAL Scientific Expert Panel. Professor Dianne Campbell has over 28 years of experience in the diagnosis and management of children with allergic…